Cargando…

Computational Drug Repurposing Approach to Identify Novel Inhibitors of ILK Protein for Treatment of Esophageal Squamous Cell Carcinoma

PURPOSE: Esophageal squamous cell cancer (ESCC) is a deadly malignant tumor characterized by an overall 5-year survival rate below 20%, with China accounting for approximately 50% of all cases worldwide. Our previous studies have demonstrated that high integrin-linked kinase (ILK) expression plays a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Juan, Ma, Xiaoli, Cao, Leiyu, Wei, Yu, Gao, Yan, Qu, Chengcheng, Maimaitiming, Nuersimanguli, Zhang, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9815933/ https://www.ncbi.nlm.nih.gov/pubmed/36618074 http://dx.doi.org/10.1155/2022/3658334

Ejemplares similares

COQ10B Knockdown Modulates Cell Proliferation, Invasion, Migration, and Apoptosis in Esophageal Squamous Cell Carcinoma
por: Wei, Yu, et al.
Publicado: (2022)

ILK predicts the efficacy of chemoradiotherapy and the prognosis of patients with esophageal squamous cell carcinoma
por: Ma, Xiao-Li, et al.
Publicado: (2019)

Computational Screening Strategy for Drug Repurposing Identified Niclosamide as Inhibitor of Vascular Calcification
por: Tanaka, Takeshi, et al.
Publicado: (2022)

Parvin-ILK: An intimate relationship
por: Vakaloglou, Katerina, et al.
Publicado: (2012)

Therapeutic Chemical Screen Identifies Phosphatase Inhibitors to Reconstitute PKB Phosphorylation and Cardiac Contractility in ILK-Deficient Zebrafish
por: Pott, Alexander, et al.
Publicado: (2018)

ILK Induces Cardiomyogenesis in the Human Heart
por: Traister, Alexandra, et al.
Publicado: (2012)

The Role of Exosomal miRNAs in Glioma: Biological Function and Clinical Application
por: Aili, Yirizhati, et al.
Publicado: (2021)

Identification of Trypanosoma cruzi Polyamine Transport Inhibitors by Computational Drug Repurposing
por: Reigada, Chantal, et al.
Publicado: (2019)

Computational Drug Repurposing for Antituberculosis Therapy: Discovery of Multi-Strain Inhibitors
por: Kleandrova, Valeria V., et al.
Publicado: (2021)

Tumor microenvironment and exosomes in brain metastasis: Molecular mechanisms and clinical application
por: Aili, Yirizhati, et al.
Publicado: (2022)

Drug repurposing using computational methods to identify therapeutic options for COVID-19
por: Mahdian, Soodeh, et al.
Publicado: (2020)

A review of computational drug repurposing
por: Park, Kyungsoo
Publicado: (2019)

Downstream Effectors of ILK in Cisplatin-Resistant Ovarian Cancer
por: Reyes-González, Jeyshka M., et al.
Publicado: (2020)

The RPL4P4 Pseudogene Is a Prognostic Biomarker and Is Associated with Immune Infiltration in Glioma
por: Wang, Zengliang, et al.
Publicado: (2022)

Expert-Augmented Computational Drug Repurposing Identified Baricitinib as a Treatment for COVID-19
por: Smith, Daniel P., et al.
Publicado: (2021)

High-throughput screen of drug repurposing library identifies inhibitors of Sarcocystis neurona growth
por: Bowden, Gregory D., et al.
Publicado: (2018)

ILK and SHP2 expression identify a poor prognostic cohort of EGFR-mutant lung cancer
por: Della Corte, Carminia Maria, et al.
Publicado: (2018)

Trends and Applications in Computationally Driven Drug Repurposing
por: Pinzi, Luca, et al.
Publicado: (2023)

Integrin-linked kinase (ILK) expression in human colon cancer
por: Bravou, V, et al.
Publicado: (2003)

ILK modulates epithelial polarity and matrix formation in hair follicles
por: Rudkouskaya, Alena, et al.
Publicado: (2014)

Non-catalytic signaling by pseudokinase ILK for regulating cell adhesion
por: Vaynberg, Julia, et al.
Publicado: (2018)

Integrin-linked kinase (ILK): the known vs. the unknown and perspectives
por: Górska, Agata, et al.
Publicado: (2022)

Epithelial morphogenesis in the Drosophila egg chamber requires Parvin and ILK
por: Keramidioti, Athina, et al.
Publicado: (2022)

Ex vivo drug sensitivity testing as a means for drug repurposing in esophageal adenocarcinoma
por: Lohse, Ines, et al.
Publicado: (2018)

Identifying FAAH Inhibitors as New Therapeutic Options for the Treatment of Chronic Pain through Drug Repurposing
por: Zanfirescu, Anca, et al.
Publicado: (2021)

Repurposing Screens of FDA-Approved Drugs Identify 29 Inhibitors of SARS-CoV-2
por: Ku, Keun Bon, et al.
Publicado: (2020)

Repurposing of Kinase Inhibitors for Treatment of COVID-19
por: Weisberg, Ellen, et al.
Publicado: (2020)

Identification of VASH1 as a Potential Prognostic Biomarker of Lower-Grade Glioma by Quantitative Proteomics and Experimental Verification
por: Aili, Yirizhati, et al.
Publicado: (2022)

Drug Repurposing Applications to Overcome Male Predominance via Targeting G2/M Checkpoint in Human Esophageal Squamous Cell Carcinoma
por: Yin, Yin, et al.
Publicado: (2022)

Computationally-guided drug repurposing enables the discovery of kinase targets and inhibitors as new schistosomicidal agents
por: Giuliani, Sandra, et al.
Publicado: (2018)

Computational repurposing of asthma drugs as potential inhibitors of SARS-CoV-2 M(pro)
por: Hussain, A., et al.
Publicado: (2022)

Computational drug repurposing of Akt-1 allosteric inhibitors for non-small cell lung cancer
por: Baby, Krishnaprasad, et al.
Publicado: (2023)

Computational-based drug repurposing methods in COVID-19
por: Masoudi-Sobhanzadeh, Yosef
Publicado: (2020)

The Impairment of ILK Related Angiogenesis Involved in Cardiac Maladaptation after Infarction
por: Xie, Jun, et al.
Publicado: (2011)

PARVA Promotes Metastasis by Modulating ILK Signalling Pathway in Lung Adenocarcinoma
por: Huang, Ay-Huey, et al.
Publicado: (2015)

An ELMO2-RhoG-ILK network modulates microtubule dynamics
por: Jackson, Bradley C., et al.
Publicado: (2015)

A new screening method for ATP-independent kinase inhibitors identifies repurposed anti-cancer drugs()
por: Timaner, Michael, et al.
Publicado: (2018)

Repurposing and computational design of PARP inhibitors as SARS-CoV-2 inhibitors
por: Rampogu, Shailima, et al.
Publicado: (2023)

High-throughput screening identified selective inhibitors of exosome biogenesis and secretion: A drug repurposing strategy for advanced cancer
por: Datta, Amrita, et al.
Publicado: (2018)

Potentially repurposable drugs for schizophrenia identified from its interactome
por: Karunakaran, Kalyani B., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3p55nnrvnaiq0bbutakc2a1l07